A draft bill introduced in May 2019 sought to reform Section 101 of the U.S. Patent Act. If passed, the legislation would allow for the patenting of genes by effectively overturning the 2013 Association for Molecular Pathology (AMP) vs. Myriad Supreme Court decision. Related: Joint Letter from ASHG and ACMG Leadership to Bill Sponsors (July... Read More
Genetics research is providing remarkable insights into the human genome and how this knowledge can be translated into healthcare advances. This scientific progress relies on continued public investment in biomedical research. ASHG supports the robust, predictable, sustainable federal funding of research to fuel scientific advances. Related: Written Testimony to Senate Appropriations LHHS Subcommittee (May 2023)... Read More
Dear ASHG Members, Today ASHG is releasing a new report on how human genetics and genomics is growing the U.S. economy and becoming increasingly integrated in healthcare and society. The new report, titled “The Economic Impact and Functional Applications of Human Genetics and Genomics,” indicates that the human genetics and genomics sector contributes $265 billion... Read More
Congratulations to our winners and thank you to all who participated. Happy DNA Day! Thank you for making this another successful year! We received many submissions from students in 40 U.S. states, and 30 countries. We would also like to thank the ASHG members who participated in judging the essays. Continue the celebration: ASHG has even... Read More
The guilty verdicts in the murder trial of Derek Chauvin deliver one measure of justice in a society that far too often fails to recognize the humanity of Black Americans. As ASHG expressed last summer following George Floyd’s murder, we know the source of inequality and inequity rests not in our biology but in “core... Read More